Cancer Drug 49 Times More Potent than Cisplatin
Tests have shown that a new cancer drug, FY26, is 49 times more potent than the clinically used treatment Cisplatin. Based on a compound of the rare precious metal osmium and developed by researchers at the University of Warwick’s Department of Chemistry and the Warwick Cancer Research Unit, FY26 is able to shut down a …